Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects
NCT02273466 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2014-10-24
Summary
To assess the steady state pharmacokinetics of Desipramine with/without concomitant administration of Crobenetine.
Conditions
- Healthy
Interventions
- DRUG
-
Desipramine tablet
- DRUG
-
Crobenetine infusion
- DRUG
-
Placebo infusion
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-02-28
- Primary Completion
- 2002-04-30
More Related Trials
-
Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
NCT00329147 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers
NCT01633437 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
NCT01774747 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine
NCT04711005 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder
NCT03446846 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Desvenlafaxine in Treating Major Depressive Disorder.
NCT04364997 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Orcinoside With Placebo in Treatment of MDD
NCT02191384 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
NCT02067793 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
NCT01052077 ·Status: COMPLETED ·Phase: PHASE2
-
Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
NCT02934035 ·Status: UNKNOWN
-
Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
NCT02196506 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT01447576 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Duloxetine in Elderly Patients With Major Depressive Disorder
NCT00062673 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine
NCT06280235 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of SDI-118 in Participants in Remission From Depression
NCT05212116 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of MD-120 in Patients With Depression
NCT04345471 ·Status: COMPLETED ·Phase: PHASE3
-
D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
NCT02772211 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression
NCT06967857 ·Status: RECRUITING ·Phase: PHASE2
-
Food and Relative Bioavailability Study
NCT00843011 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Intermittent Doses of CERC-301 in MDD
NCT02459236 ·Status: COMPLETED ·Phase: PHASE2
-
Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
NCT01913535 ·Status: TERMINATED ·Phase: PHASE2
-
Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers
NCT03420469 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Antidepressant Medication Plus Donepezil for Treating Late-life Depression
NCT00177671 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Metabolism and Antidepressant
NCT02438072 ·Status: UNKNOWN ·Phase: NA
-
Study of Fluoxetine in Patients With Depersonalization Disorder
NCT00004446 ·Status: COMPLETED ·Phase: NA